Principles and Practice of Pharmacovigilance and Drug Safety
The science of drug safety and pharmacovigilance has rapidly evolved in the 21st century. The knowledge and principles it contains are of increasing importance in clinical and practice settings. The aim of this book is to deal with the gap in knowledge about pharmacovigilance and drug safety, includ...
Guardat en:
| Autor corporatiu: | |
|---|---|
| Altres autors: | , , |
| Format: | Electrònic eBook |
| Idioma: | anglès |
| Publicat: |
Cham :
Springer International Publishing : Imprint: Springer,
2024.
|
| Edició: | 1st ed. 2024. |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1007/978-3-031-51089-2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
MARC
| LEADER | 00000nam a22000005i 4500 | ||
|---|---|---|---|
| 001 | 978-3-031-51089-2 | ||
| 003 | DE-He213 | ||
| 005 | 20260907145233.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 240805s2024 sz | o |||| 0|eng d | ||
| 020 | |a 9783031510892 |9 978-3-031-51089-2 | ||
| 024 | 7 | |a 10.1007/978-3-031-51089-2 |2 doi | |
| 050 | 4 | |a RM302.5 | |
| 072 | 7 | |a MMG |2 bicssc | |
| 072 | 7 | |a MED071000 |2 bisacsh | |
| 072 | 7 | |a MKG |2 thema | |
| 082 | 0 | 4 | |a 353.998 |2 23 |
| 245 | 1 | 0 | |a Principles and Practice of Pharmacovigilance and Drug Safety |h [electronic resource] / |c edited by Jimmy Jose, Anthony R. Cox, Vibhu Paudyal. |
| 250 | |a 1st ed. 2024. | ||
| 264 | 1 | |a Cham : |b Springer International Publishing : |b Imprint: Springer, |c 2024. | |
| 300 | |a 1 online resource (XVI, 561 p. 49 illus.). |b 42 illus. in color. | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 341 | 0 | |b Table of contents navigation |2 onix | |
| 341 | 0 | |b Single logical reading order |2 onix | |
| 341 | 0 | |b Short alternative textual descriptions |2 onix | |
| 341 | 0 | |b Use of colour is Not sole means of conveying information |2 onix | |
| 341 | 0 | |b Use of high contrast between text and background colour |2 onix | |
| 341 | 0 | |b Next / Previous structural navigation |2 onix | |
| 341 | 0 | |b All Non-decorative content supports reading without sight |2 onix | |
| 347 | |a text file |b PDF |2 rda | ||
| 505 | 0 | |a Part I. Principles and Practice of Pharmacovigilance and Drug Safety -- Overview of Drug Safety -- An Overview Of Immunological Reactions To Drugs -- Predisposing Factors for Adverse Drug Reactions -- Drug interactions and their management -- Economics of medication safety -- Principles Of Pharmacovigilance And Drug Regulation -- Clinical Trials Safety Data -- Causality Assessment in Pharmacovigilance -- A Retrospective and Prospective Look at Pharmacoepidemiology -- Communicating drug safety -- Patient involvement in pharmacovigilance -- Collaborative Approaches to Establishing and Implementing Pharmacovigilance Systems -- Part II. Safer Prescribing and Drug use in Practice -- Medication Errors in Healthcare -- Spontaneous Reporting Systems -- Methods to Identify, Prevent, Predict and Manage Adverse Drug Reactions in Pharmacovigilance and Clinical Practice -- Ethics in Pharmacovigilance -- Information Sources for Drug Safety and Communicating Risks in Clinical Practice -- Polypharmacy and Deprescribing -- Medication Prescribing and Safety Monitoring in Paediatrics -- Prescribing and Safety Monitoring in the Older Person -- Safe Prescribing and Drug use in Pregnancy and Breastfeeding -- Safe Prescribing in Patients with Renal and Hepatic Diseases -- Clinical Application of Pharmacogenomics in Improving Drug Safety. | |
| 520 | |a The science of drug safety and pharmacovigilance has rapidly evolved in the 21st century. The knowledge and principles it contains are of increasing importance in clinical and practice settings. The aim of this book is to deal with the gap in knowledge about pharmacovigilance and drug safety, including the application of pharmacovigilance knowledge to individual patient cases in clinical practice. A holistic approach is taken with each chapter written from the perspective of a practitioner, industry personnel, researcher, or regulator, creating a synergy between drug safety, pharmacovigilance, and clinical practice. Chapters offer key material on adverse drug reactions, medication errors, prescribing safety, pharmacovigilance as well as data sources used in drug safety and pharmacovigilance. Each chapter is structured as a self-contained learning resource, with learning objectives, and worked cases. The book is suitable for undergraduate healthcare professions, postgraduate students, researchers, clinical practitioners – including those with prescribing responsibilities. It will also be useful for professionals moving from a clinical practice role to a specialist pharmacovigilance role. For those already in a pharmacovigilance role, the book offers insight into the theory and practice of drug safety and pharmacovigilance in clinical settings. | ||
| 532 | 8 | |a Accessibility summary: This PDF does Not fully comply with PDF/UA standards but does include limited screen reader support, descriptions for Non-text content (such as images and graphs), bookmarks for easy navigation, and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognise the importance of accessibility and welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us via https://www.springernature.com/gp/info/accessibility | |
| 532 | 8 | |a Inaccessible, or known limited accessibility | |
| 532 | 8 | |a No reading system accessibility options actively disabled | |
| 532 | 8 | |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com | |
| 588 | |a Print version record. | ||
| 650 | 0 | |a Pharmacovigilance. | |
| 650 | 0 | |a Medicine. | |
| 650 | 0 | |a Pharmacy. | |
| 650 | 0 | |a Nursing. | |
| 650 | 0 | |a Dentistry. | |
| 650 | 0 | |a Medical care. | |
| 650 | 1 | 4 | |a Drug Safety and Pharmacovigilance. |
| 650 | 2 | 4 | |a Clinical Medicine. |
| 650 | 2 | 4 | |a Pharmacy. |
| 650 | 2 | 4 | |a Nursing. |
| 650 | 2 | 4 | |a Dentistry. |
| 650 | 2 | 4 | |a Health Care. |
| 700 | 1 | |a Jose, Jimmy. |e editor. |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Cox, Anthony R. |e editor. |0 (orcid)0000-0003-2294-3440 |1 https://orcid.org/0000-0003-2294-3440 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 700 | 1 | |a Paudyal, Vibhu. |e editor. |0 (orcid)0000-0002-4173-6490 |1 https://orcid.org/0000-0002-4173-6490 |4 edt |4 http://id.loc.gov/vocabulary/relators/edt | |
| 710 | 2 | |a SpringerLink (Online service) | |
| 773 | 0 | |t Springer Nature eBook | |
| 776 | 0 | 8 | |i Printed edition: |z 9783031510885 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031510908 |
| 776 | 0 | 8 | |i Printed edition: |z 9783031510915 |
| 856 | 4 | 0 | |u https://doi.org/10.1007/978-3-031-51089-2 |
| 912 | |a ZDB-2-SBL | ||
| 912 | |a ZDB-2-SXB | ||
| 950 | |a Biomedical and Life Sciences (SpringerNature-11642) | ||
| 950 | |a Biomedical and Life Sciences (R0) (SpringerNature-43708) | ||